#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Red blood cell abnormality Trigeminal neuralgia Haemophilia A without inhibitors Pericarditis Glomerulonephritis acute Pleural mesothelioma malignant Ductal adenocarcinoma of pancreas Hepatitis B Hypoxic-ischaemic encephalopathy Endocrine ophthalmopathy Basal cell naevus syndrome Small cell lung cancer extensive stage VEXAS syndrome Fusarium infection Still's disease More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent Osteosarcoma metastatic – Treatment Leiomyosarcoma metastatic Ornithine transcarbamoylase deficiency – Diagnostics Pemphigus Behcet’s syndrome – Diagnostics Ewing’s sarcoma – Life with Disease Rhabdomyosarcoma – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Systemic sclerosis pulmonary – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALE1 Vx-522 Vonicog Alfa Adalimumab 13N-AMMONIA Carvedilol Sqy51 Dexketoprofen Methotrexate Guanabenz Acetate Itolizumab Posdinemab Pegunigalsidase Alfa Amphotericine B, Liposome Everolimus Cobimetinib Saline Poltreg-T1D Tavapadon Toripalimab More therapies…

    Learn about Your Condition

    Trigeminal neuralgia Herpes simplex reactivation Inborn error of metabolism Biliary tract operation Mixed-type liposarcoma Lichen planus Rhabdomyosarcoma recurrent Behcet's syndrome Thromboembolectomy Neuropathy peripheral Infective uveitis Myasthenia gravis Deep vein thrombosis Persistent depressive disorder Precocious puberty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Safety of NG004 for Patients with Acute Spinal Cord Injury

    Recruiting

    1 1 1
    Investigated Diseases:
    • Spinal cord injury cervical
    Investigated Drugs:
    • Ng004
    Germany

  • Study on the Effectiveness and Safety of DNL310 vs Idursulfase for Children and Young Adults with Mucopolysaccharidosis Type II

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis II
    Investigated Drugs:
    • Iduronate-2-Sulfatase Fused To A Fc Polypeptide That Binds To The Human Transferrin Receptor
    • Idursulfase
    Belgium Czechia France Germany Italy The Netherlands +2

  • Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Istradefylline
    Finland

  • Study on Neural Stem Cell and Sodium Chloride Treatment for Patients with Amyotrophic Lateral Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Sodium Chloride Ph. Eur.
    Italy

  • Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

    Recruiting

    2 1
    Investigated Drugs:
    • Medi0618
    Czechia Denmark Germany Hungary Italy The Netherlands +2

  • Study on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Simvastatin
    • Atorvastatin
    Spain
Previous Page
1 … 37 38 39 40 41 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!